A Phase 2 Study of Doripenem In The Treatment of Nosocomial and Ventilator-Associated Pneumonia In Hospitals

Trial Profile

A Phase 2 Study of Doripenem In The Treatment of Nosocomial and Ventilator-Associated Pneumonia In Hospitals

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Sep 2013

At a glance

  • Drugs Doripenem (Primary)
  • Indications Bacterial infections; Nosocomial pneumonia
  • Focus Therapeutic Use
  • Sponsors PriCara
  • Most Recent Events

    • 04 Jul 2012 Additional lead trial centre identified as reported by EudraCT.
    • 04 Jul 2012 Planned number of patients changed from 200 to 1000 as reported by EudraCT.
    • 04 Jul 2012 Additional trial location (France) identified as reported by EudraCT.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top